MCID: SLN001
MIFTS: 25

Silent Myocardial Infarction

Categories: Cardiovascular diseases

Aliases & Classifications for Silent Myocardial Infarction

MalaCards integrated aliases for Silent Myocardial Infarction:

Name: Silent Myocardial Infarction 12 15 74

Classifications:



External Ids:

Disease Ontology 12 DOID:5854
NCIt 51 C35400
UMLS 74 C0340324

Summaries for Silent Myocardial Infarction

MalaCards based summary : Silent Myocardial Infarction is related to acute myocardial infarction and myocardial infarction. An important gene associated with Silent Myocardial Infarction is AGTR1 (Angiotensin II Receptor Type 1). The drugs Gliclazide and Metformin have been mentioned in the context of this disorder. Affiliated tissues include heart and kidney.

Related Diseases for Silent Myocardial Infarction

Graphical network of the top 20 diseases related to Silent Myocardial Infarction:



Diseases related to Silent Myocardial Infarction

Symptoms & Phenotypes for Silent Myocardial Infarction

Drugs & Therapeutics for Silent Myocardial Infarction

Drugs for Silent Myocardial Infarction (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 65)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1
Gliclazide Approved Phase 4 21187-98-4 3475
2
Metformin Approved Phase 4 657-24-9 14219 4091
3
Glimepiride Approved Phase 4,Phase 3 93479-97-1 3476
4
Pioglitazone Approved, Investigational Phase 4 111025-46-8 4829
5
Glyburide Approved Phase 4 10238-21-8 3488
6
Cobalt Approved, Experimental Phase 4 7440-48-4 104729
7
Chromium Approved Phase 4 7440-47-3 27668
8
Nitrous oxide Approved, Vet_approved Phase 4 10024-97-2 948
9
2,4-thiazolidinedione Investigational Phase 4 2295-31-0
10 Hypoglycemic Agents Phase 4,Phase 3
11 Trace Elements Phase 4
12 Micronutrients Phase 4
13 Nutrients Phase 4
14 Peripheral Nervous System Agents Phase 4
15 Analgesics Phase 4
16 Central Nervous System Depressants Phase 4
17 Anesthetics Phase 4
18 Anesthetics, Inhalation Phase 4
19 Anesthetics, General Phase 4
20 Analgesics, Non-Narcotic Phase 4
21
Empagliflozin Approved Phase 3 864070-44-0
22
Pravastatin Approved Phase 3 81093-37-0 54687
23
Lovastatin Approved, Investigational Phase 3 75330-75-5 53232
24
Fenofibrate Approved Phase 3 49562-28-9 3339
25
Atorvastatin Approved Phase 3 134523-00-5 60823
26
Ezetimibe Approved Phase 3 163222-33-1 150311
27
Nicotinamide Approved, Investigational Phase 3 98-92-0 936
28
Simvastatin Approved Phase 3 79902-63-9 54454
29
Linagliptin Approved Phase 3 668270-12-0 10096344
30 Nutmeg Approved Phase 3
31
Warfarin Approved Phase 3 81-81-2 54678486 6691
32
Niacin Approved, Investigational, Nutraceutical Phase 3 59-67-6 938
33
Serine Approved, Nutraceutical Phase 3 56-45-1 5951
34
Darapladib Investigational Phase 3 356057-34-6 9939609
35
Dabigatran Investigational Phase 3 211914-51-1
36 Sodium-Glucose Transporter 2 Inhibitors Phase 3
37 Clofibric Acid Phase 3 882-09-7
38 Eicosapentaenoic acid ethyl ester Phase 3
39 Hydroxymethylglutaryl-CoA Reductase Inhibitors Phase 3
40 Omega 3 Fatty Acid Phase 3
41 Lipid Regulating Agents Phase 3
42 Rosuvastatin Calcium Phase 3 147098-20-2
43 Anticholesteremic Agents Phase 3
44 Nicotinic Acids Phase 3
45 Ezetimibe, Simvastatin Drug Combination Phase 3
46 Hypolipidemic Agents Phase 3
47 L 647318 Phase 3
48 Vitamin B3 Phase 3
49 Platelet Aggregation Inhibitors Phase 3
50 Dihydromevinolin Phase 3

Interventional clinical trials:

(show all 13)
# Name Status NCT ID Phase Drugs
1 Thiazolidinediones Or Sulphonylureas and Cardiovascular Accidents.Intervention Trial Unknown status NCT00700856 Phase 4 add-on pioglitazone;add-on sulphonylurea
2 Comparative Phase IV Study: Efficacy And Safety of TiTAN2 Versus COBALT-CHROME Stents- EVIDENCEII Unknown status NCT01918150 Phase 4
3 The ENIGMA II Trial:Nitrous Oxide Anaesthesia and Cardiac Morbidity After Major Surgery: a Randomised Controlled Trial Completed NCT00430989 Phase 4 Nitrous Oxide;Nitrous Oxide
4 BI 10773 (Empagliflozin) Cardiovascular Outcome Event Trial in Type 2 Diabetes Mellitus Patients (EMPA-REG OUTCOME). Completed NCT01131676 Phase 3 BI 10773 low dose;Placebo BI 10773 high dose;BI 10773 high dose;Placebo BI 10773 low dose;Placebo BI 10773 low dose;Placebo BI 10773 high dose
5 A Study of AMR101 to Evaluate Its Ability to Reduce Cardiovascular Events in High Risk Patients With Hypertriglyceridemia and on Statin. The Primary Objective is to Evaluate the Effect of 4 g/Day AMR101 for Preventing the Occurrence of a First Major Cardiovascular Event. Completed NCT01492361 Phase 3 AMR101;Placebo
6 CAROLINA: Cardiovascular Outcome Study of Linagliptin Versus Glimepiride in Patients With Type 2 Diabetes Completed NCT01243424 Phase 3 linagliptin;glimepiride;linagliptin placebo;glimepride placebo
7 The Stabilization Of pLaques usIng Darapladib-Thrombolysis In Myocardial Infarction 52 Trial Completed NCT01000727 Phase 3 Darapladib 160 mg;Placebo
8 The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial Completed NCT00799903 Phase 3 Darapladib;Placebo
9 Randomized Evaluation of Long Term Anticoagulant Therapy (RE-LY) With Dabigatran Etexilate Completed NCT00262600 Phase 3 warfarin;Dabigatran dose 1;Dabigatran dose 2
10 RELY-ABLE Long Term Multi-center Extension of Dabigatran Treatment in Patients With Atrial Fibrillation Who Completed RE-LY Trial Completed NCT00808067 Phase 3 dabigatran dose 1;dabigatran dose 2
11 MYOCARDIAL SILENT INFARCTIONS AND FIBROSIS IN FAMILIAL HYPERCHOLESTEROLEMIA (CHOLCOEUR) Unknown status NCT02517944
12 Pain Perception is Attenuated in Patients With Painless Myocardial Infarction Completed NCT00192790
13 Microparticles in Obstructive Sleep Apnea Recruiting NCT03438149

Search NIH Clinical Center for Silent Myocardial Infarction

Genetic Tests for Silent Myocardial Infarction

Anatomical Context for Silent Myocardial Infarction

MalaCards organs/tissues related to Silent Myocardial Infarction:

42
Heart, Kidney

Publications for Silent Myocardial Infarction

Articles related to Silent Myocardial Infarction:

(show top 50) (show all 83)
# Title Authors Year
1
Congestive heart failure caused by silent ischemia and silent myocardial infarction : Diagnostic challenge in type 2 diabetes. ( 30899966 )
2019
2
Incidentally discovered left ventricular pseudoaneurysm after silent myocardial infarction occurred in a young woman with peritoneal dialysis. ( 30859192 )
2019
3
Interrelationships Between American Heart Association's Life's Simple 7, ECG Silent Myocardial Infarction, and Cardiovascular Mortality. ( 30859894 )
2019
4
Interrelations Between Serum Uric Acid, Silent Myocardial Infarction, and Mortality in the General Population. ( 30617009 )
2019
5
Silent myocardial infarction and risk of heart failure: Current evidence and gaps in knowledge. ( 30224236 )
2019
6
Long-Term Prognostic Implications of Previous Silent Myocardial Infarction in Patients Presenting With Acute Myocardial Infarction. ( 29680352 )
2018
7
A Combination of Tachycardia-Mediated Heart Failure and Coronary Artery Vasospasm-Induced Silent Myocardial Infarction in a Patient with Severe Thyrotoxicosis. ( 29713551 )
2018
8
A silent myocardial infarction with normal coronary arteries associated with Graves' disease. ( 30503299 )
2018
9
Silent myocardial infarction and risk of heart failure. ( 30613610 )
2018
10
Silent Myocardial Infarction and Long-Term Risk of Heart Failure: The ARIC Study. ( 29301615 )
2018
11
Silent Myocardial Infarction: Listen to the Evidence. ( 29301632 )
2018
12
Acute coronary syndromes: Silent myocardial infarction increases the risk of heart failure. ( 29368702 )
2018
13
Correction: Sudden death associated with silent myocardial infarction in a 35-year-old man: a case report. ( 29471871 )
2018
14
Unruptured giant left ventricular pseudoaneurysm after silent myocardial infarction. ( 30021745 )
2018
15
Prognostic value of silent myocardial infarction in patients with chronic kidney disease being evaluated for kidney transplantation. ( 28958755 )
2017
16
Woven coronary anomaly leading to silent myocardial infarction: A case report. ( 29095260 )
2017
17
Electrocardiographic QRS-T angle and the risk of incident silent myocardial infarction in the Atherosclerosis Risk in Communities study. ( 28515002 )
2017
18
Silent myocardial infarction secondary to cardiac autonomic neuropathy in a patient with rheumatoid arthritis. ( 27489064 )
2016
19
Sudden death associated with silent myocardial infarction in a 35-year-old man: a case report. ( 26925778 )
2016
20
Race and Sex Differences in the Incidence and Prognostic Significance of Silent Myocardial Infarction in the Atherosclerosis Risk in Communities (ARIC) Study. ( 27185168 )
2016
21
Association of cardiovascular disease risk factors with left ventricular mass, biventricular function, and the presence of silent myocardial infarction on cardiac MRI in an asymptomatic population. ( 27209284 )
2016
22
A Novel and Practical Screening Tool for the Detection of Silent Myocardial Infarction in Patients With Type 2 Diabetes. ( 27300573 )
2016
23
Erratum to: Association of cardiovascular disease risk factors with left ventricular mass, biventricular function, and the presence of silent myocardial infarction on cardiac MRI in an asymptomatic population. ( 27376356 )
2016
24
A rare long-term survival of the life-threatening trio: silent myocardial infarction complicated by ventricular septal rupture, type 2 diabetes mellitus and chronic bronchitis. ( 26543616 )
2015
25
Silent myocardial infarction and stroke: findings of multimodality imaging. ( 25514927 )
2015
26
A new cause of silent myocardial infarction: Bonsai. ( 25550251 )
2015
27
Prognostic significance of silent myocardial infarction in newly diagnosed type 2 diabetes mellitus: United Kingdom Prospective Diabetes Study (UKPDS) 79. ( 23362315 )
2013
28
Prevalence, extent, and independent predictors of silent myocardial infarction. ( 23597799 )
2013
29
A silent myocardial infarction in the diabetes outpatient clinic: case report and review of the literature. ( 24616778 )
2013
30
Silent myocardial infarction during hypoglycemic coma. ( 22276266 )
2012
31
Is silent myocardial infarction more common in women with type 2 diabetes than in men? ( 22446034 )
2012
32
An unusual case of left ventricular free wall rupture caused by a silent myocardial infarction. ( 23170099 )
2012
33
Silent myocardial infarction subsequent to cutaneous polyarteritis nodosa in a patient with positive lupus anticoagulant. ( 21763578 )
2011
34
Prevalence, incidence, predictive factors and prognosis of silent myocardial infarction: a review of the literature. ( 21497307 )
2011
35
Coronary aneurysm and silent myocardial infarction in an adolescent secondary to undiagnosed childhood Kawasaki disease. ( 20664770 )
2010
36
Incidence and predictors of silent myocardial infarction in type 2 diabetes and the effect of fenofibrate: an analysis from the Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) study. ( 19797259 )
2010
37
Silent myocardial infarction: the risk beyond the first admission. ( 20813725 )
2010
38
Does silent myocardial infarction add prognostic value in ST-elevation myocardial infarction patients without a history of prior myocardial infarction? Insights from the Assessment of Pexelizumab in Acute Myocardial Infarction (APEX-AMI) Trial. ( 20934561 )
2010
39
Cerebral transient ischemic attack due to left ventricular thrombus formation in a young patient with silent myocardial infarction and normal coronary arteries. ( 18160151 )
2009
40
Giant left ventricular aneurysm and intraventricular septal defect after silent myocardial infarction. ( 19329416 )
2009
41
Silent myocardial infarction in women with type II diabetes mellitus and microalbuminuria. ( 19209251 )
2008
42
The impact of remote patient monitoring in managing silent myocardial infarction in a residential home setting. ( 17584720 )
2007
43
Paradoxical mesentery embolism and silent myocardial infarction in primary antiphospholipid syndrome: a case report. ( 16543157 )
2006
44
Giant left-ventricular pseudoaneurysm following silent myocardial infarction. ( 16428885 )
2006
45
Unruptured giant left ventricular pseudoaneurysm complicating silent myocardial infarction in a diabetic young adult: left ventricular giant pseudoaneurysm after silent myocardial infarction. ( 16015433 )
2005
46
Silent myocardial infarction and its prognosis in a community-based cohort of Type 2 diabetic patients: the Fremantle Diabetes Study. ( 14963648 )
2004
47
Small vessel vasculitis with pulmonary aneurysms and silent myocardial infarction. ( 12869681 )
2003
48
Detection of a silent myocardial infarction with phosphor-31 two-dimensional chemical shift imaging (31P 2-D CSI). ( 12928747 )
2003
49
Silent myocardial infarction in women with impaired glucose tolerance: the Northern Sweden MONICA study. ( 14498994 )
2003
50
Silent myocardial infarction in Wegener's granulomatosis. ( 8612034 )
1996

Variations for Silent Myocardial Infarction

Expression for Silent Myocardial Infarction

Search GEO for disease gene expression data for Silent Myocardial Infarction.

Pathways for Silent Myocardial Infarction

GO Terms for Silent Myocardial Infarction

Sources for Silent Myocardial Infarction

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
17 EFO
18 ExPASy
20 FMA
29 GO
30 GTR
31 HGMD
32 HMDB
33 HPO
34 ICD10
35 ICD10 via Orphanet
36 ICD9CM
37 IUPHAR
38 KEGG
39 LifeMap
41 LOVD
43 MedGen
45 MeSH
46 MESH via Orphanet
47 MGI
50 NCI
51 NCIt
52 NDF-RT
55 NINDS
56 Novoseek
58 OMIM
59 OMIM via Orphanet
63 PubMed
65 QIAGEN
70 SNOMED-CT via HPO
71 SNOMED-CT via Orphanet
72 TGDB
73 Tocris
74 UMLS
75 UMLS via Orphanet
Content
Loading form....